Skip to main content
PMC home page
American Journal of Human Genetics logoLink to American Journal of Human Genetics
. 2000 Apr 4;66(5):1569–1579. doi: 10.1086/302906

Association between the surfactant protein A (SP-A) gene locus and respiratory-distress syndrome in the Finnish population.

M Rämet 1, R Haataja 1, R Marttila 1, J Floros 1, M Hallman 1
PMCID: PMC1378016  PMID: 10762543

Abstract

Respiratory-distress syndrome (RDS) in the newborn is a major cause of neonatal mortality and morbidity. Although prematurity is the most-important risk factor for RDS, the syndrome does not develop in many premature infants. The main cause of RDS is a deficiency of pulmonary surfactant, which consists of phospholipids and specific proteins. The genes underlying susceptibility to RDS are insufficiently known. The candidate-gene approach was used to study the association between the surfactant protein A (SP-A) gene locus and RDS in the genetically homogeneous Finnish population. In the present study, 88 infants with RDS and 88 control infants that were matched for degree of prematurity, prenatal glucocorticoid therapy, and sex were analyzed for SP-A genotypes. We show that certain SP-A1 alleles (6A2 and 6A3) and an SP-A1/SP-A2 haplotype (6A2/1A0) were associated with RDS. The 6A2 allele was overrepresented and the 6A3 allele was underrepresented in infants with RDS. These associations were particularly strong among small premature infants born at gestational age <32 wk. In infants protected from RDS (those that had no RDS, despite extreme prematurity and lack of glucocorticoid therapy), compared with infants that had RDS develop despite having received glucocorticoid therapy, the frequencies of 6A2 (.22 vs.71), 6A3 (.72 vs.17), 6A2/1A0 (.17 vs.68), 6A3/1A1 (.39 vs.10), and 6A3/1A2 (.28 vs.06) in the two groups, respectively, were strikingly different. According to the results of conditional logistic-regression analysis, diseases associated with premature birth did not explain the association between the odds of a particular homozygous SP-A1 genotype (6A2/6A2 and 6A3/6A3) and RDS. In the population evaluated in the present study, SP-B intron 4 variant frequencies were low and had no detectable association with RDS. We conclude that the SP-A gene locus is an important determinant for predisposition to RDS in premature infants.

Full Text

The Full Text of this article is available as a PDF (272.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AVERY M. E., MEAD J. Surface properties in relation to atelectasis and hyaline membrane disease. AMA J Dis Child. 1959 May;97(5 Pt 1):517–523. doi: 10.1001/archpedi.1959.02070010519001. [DOI] [PubMed] [Google Scholar]
  2. Bruns G., Stroh H., Veldman G. M., Latt S. A., Floros J. The 35 kd pulmonary surfactant-associated protein is encoded on chromosome 10. Hum Genet. 1987 May;76(1):58–62. doi: 10.1007/BF00283051. [DOI] [PubMed] [Google Scholar]
  3. Cockshutt A. M., Weitz J., Possmayer F. Pulmonary surfactant-associated protein A enhances the surface activity of lipid extract surfactant and reverses inhibition by blood proteins in vitro. Biochemistry. 1990 Sep 11;29(36):8424–8429. doi: 10.1021/bi00488a032. [DOI] [PubMed] [Google Scholar]
  4. Crouch E. C. Collectins and pulmonary host defense. Am J Respir Cell Mol Biol. 1998 Aug;19(2):177–201. doi: 10.1165/ajrcmb.19.2.140. [DOI] [PubMed] [Google Scholar]
  5. Crowley P. A. Antenatal corticosteroid therapy: a meta-analysis of the randomized trials, 1972 to 1994. Am J Obstet Gynecol. 1995 Jul;173(1):322–335. doi: 10.1016/0002-9378(95)90222-8. [DOI] [PubMed] [Google Scholar]
  6. DiAngelo S., Lin Z., Wang G., Phillips S., Ramet M., Luo J., Floros J. Novel, non-radioactive, simple and multiplex PCR-cRFLP methods for genotyping human SP-A and SP-D marker alleles. Dis Markers. 1999 Dec;15(4):269–281. doi: 10.1155/1999/961430. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Eggleton P., Reid K. B. Lung surfactant proteins involved in innate immunity. Curr Opin Immunol. 1999 Feb;11(1):28–33. doi: 10.1016/s0952-7915(99)80006-5. [DOI] [PubMed] [Google Scholar]
  8. Farrell P. M., Wood R. E. Epidemiology of hyaline membrane disease in the United States: analysis of national mortality statistics. Pediatrics. 1976 Aug;58(2):167–176. [PubMed] [Google Scholar]
  9. Fisher J. H., Kao F. T., Jones C., White R. T., Benson B. J., Mason R. J. The coding sequence for the 32,000-dalton pulmonary surfactant-associated protein A is located on chromosome 10 and identifies two separate restriction-fragment-length polymorphisms. Am J Hum Genet. 1987 Jun;40(6):503–511. [PMC free article] [PubMed] [Google Scholar]
  10. Floros J., DiAngelo S., Koptides M., Karinch A. M., Rogan P. K., Nielsen H., Spragg R. G., Watterberg K., Deiter G. Human SP-A locus: allele frequencies and linkage disequilibrium between the two surfactant protein A genes. Am J Respir Cell Mol Biol. 1996 Oct;15(4):489–498. doi: 10.1165/ajrcmb.15.4.8879183. [DOI] [PubMed] [Google Scholar]
  11. Floros J., Hoover R. R. Genetics of the hydrophilic surfactant proteins A and D. Biochim Biophys Acta. 1998 Nov 19;1408(2-3):312–322. doi: 10.1016/s0925-4439(98)00077-5. [DOI] [PubMed] [Google Scholar]
  12. Floros J., Kala P. Surfactant proteins: molecular genetics of neonatal pulmonary diseases. Annu Rev Physiol. 1998;60:365–384. doi: 10.1146/annurev.physiol.60.1.365. [DOI] [PubMed] [Google Scholar]
  13. Floros J., Phelps D. S., deMello D. E., Longmate J., Harding H., Benson B., White T. The utility of postmortem lung for RNA studies; variability and correlation of the expression of surfactant proteins in human lung. Exp Lung Res. 1991 Jan-Feb;17(1):91–104. doi: 10.3109/01902149109063284. [DOI] [PubMed] [Google Scholar]
  14. Floros J., Veletza S. V., Kotikalapudi P., Krizkova L., Karinch A. M., Friedman C., Buchter S., Marks K. Dinucleotide repeats in the human surfactant protein-B gene and respiratory-distress syndrome. Biochem J. 1995 Jan 15;305(Pt 2):583–590. doi: 10.1042/bj3050583. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. GRAVEN S. N., MISENHEIMER H. R. RESPIRATORY DISTRESS SYNDROME AND THE HIGH RISK MOTHER. Am J Dis Child. 1965 Jun;109:489–494. doi: 10.1001/archpedi.1965.02090020491003. [DOI] [PubMed] [Google Scholar]
  16. Gluck L., Kulovich M. V., Borer R. C., Jr, Brenner P. H., Anderson G. G., Spellacy W. N. Diagnosis of the respiratory distress syndrome by amniocentesis. Am J Obstet Gynecol. 1971 Feb 1;109(3):440–445. doi: 10.1016/0002-9378(71)90342-5. [DOI] [PubMed] [Google Scholar]
  17. Hafez M., el-Sallab S., Khashaba M., Risk M. S., el-Morsy Z., Bassiony M. R., el-Kenawy F., Zaghloul W. Evidence of HLA-linked susceptibility gene(s) in respiratory distress syndrome. Dis Markers. 1989 Oct-Dec;7(4):201–208. [PubMed] [Google Scholar]
  18. Hallman M., Arjomaa P., Mizumoto M., Akino T. Surfactant proteins in the diagnosis of fetal lung maturity. I. Predictive accuracy of the 35 kD protein, the lecithin/sphingomyelin ratio, and phosphatidylglycerol. Am J Obstet Gynecol. 1988 Mar;158(3 Pt 1):531–535. doi: 10.1016/0002-9378(88)90019-1. [DOI] [PubMed] [Google Scholar]
  19. Hallman M., Merritt T. A., Akino T., Bry K. Surfactant protein A, phosphatidylcholine, and surfactant inhibitors in epithelial lining fluid. Correlation with surface activity, severity of respiratory distress syndrome, and outcome in small premature infants. Am Rev Respir Dis. 1991 Dec;144(6):1376–1384. doi: 10.1164/ajrccm/144.6.1376. [DOI] [PubMed] [Google Scholar]
  20. Hawgood S., Clements J. A. Pulmonary surfactant and its apoproteins. J Clin Invest. 1990 Jul;86(1):1–6. doi: 10.1172/JCI114670. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Hoover R. R., Floros J. SP-A 3'-UTR is involved in the glucocorticoid inhibition of human SP-A gene expression. Am J Physiol. 1999 Jun;276(6 Pt 1):L917–L924. doi: 10.1152/ajplung.1999.276.6.L917. [DOI] [PubMed] [Google Scholar]
  22. Ikegami M., Korfhagen T. R., Whitsett J. A., Bruno M. D., Wert S. E., Wada K., Jobe A. H. Characteristics of surfactant from SP-A-deficient mice. Am J Physiol. 1998 Aug;275(2 Pt 1):L247–L254. doi: 10.1152/ajplung.1998.275.2.L247. [DOI] [PubMed] [Google Scholar]
  23. Kala P., Ten Have T., Nielsen H., Dunn M., Floros J. Association of pulmonary surfactant protein A (SP-A) gene and respiratory distress syndrome: interaction with SP-B. Pediatr Res. 1998 Feb;43(2):169–177. doi: 10.1203/00006450-199802000-00003. [DOI] [PubMed] [Google Scholar]
  24. Karinch A. M., Floros J. 5' splicing and allelic variants of the human pulmonary surfactant protein A genes. Am J Respir Cell Mol Biol. 1995 Jan;12(1):77–88. doi: 10.1165/ajrcmb.12.1.7811473. [DOI] [PubMed] [Google Scholar]
  25. Karinch A. M., deMello D. E., Floros J. Effect of genotype on the levels of surfactant protein A mRNA and on the SP-A2 splice variants in adult humans. Biochem J. 1997 Jan 1;321(Pt 1):39–47. doi: 10.1042/bj3210039. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Korfhagen T. R., Bruno M. D., Ross G. F., Huelsman K. M., Ikegami M., Jobe A. H., Wert S. E., Stripp B. R., Morris R. E., Glasser S. W. Altered surfactant function and structure in SP-A gene targeted mice. Proc Natl Acad Sci U S A. 1996 Sep 3;93(18):9594–9599. doi: 10.1073/pnas.93.18.9594. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Lankenau H. M. A genetic and statistical study of the respiratory distress syndrome. Eur J Pediatr. 1976 Oct 1;123(3):167–177. doi: 10.1007/BF00452094. [DOI] [PubMed] [Google Scholar]
  28. Lin Z., deMello D. E., Wallot M., Floros J. An SP-B gene mutation responsible for SP-B deficiency in fatal congenital alveolar proteinosis: evidence for a mutation hotspot in exon 4. Mol Genet Metab. 1998 May;64(1):25–35. doi: 10.1006/mgme.1998.2702. [DOI] [PubMed] [Google Scholar]
  29. Moya F. R., Montes H. F., Thomas V. L., Mouzinho A. M., Smith J. F., Rosenfeld C. R. Surfactant protein A and saturated phosphatidylcholine in respiratory distress syndrome. Am J Respir Crit Care Med. 1994 Dec;150(6 Pt 1):1672–1677. doi: 10.1164/ajrccm.150.6.7952631. [DOI] [PubMed] [Google Scholar]
  30. Myrianthopoulos N. C., Churchill J. A., Baszynski A. J. Respiratory distress syndrome in twins. Acta Genet Med Gemellol (Roma) 1971 Apr;20(2):199–204. doi: 10.1017/s1120962300011628. [DOI] [PubMed] [Google Scholar]
  31. Nogee L. M., Garnier G., Dietz H. C., Singer L., Murphy A. M., deMello D. E., Colten H. R. A mutation in the surfactant protein B gene responsible for fatal neonatal respiratory disease in multiple kindreds. J Clin Invest. 1994 Apr;93(4):1860–1863. doi: 10.1172/JCI117173. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Olowe S. A., Akinkugbe A. Amniotic fluid lecithin/sphingomyelin ratio: comparison between an African and North American community. Pediatrics. 1978 Jul;62(1):38–41. [PubMed] [Google Scholar]
  33. Peltonen L., Pekkarinen P., Aaltonen J. Messages from an isolate: lessons from the Finnish gene pool. Biol Chem Hoppe Seyler. 1995 Dec;376(12):697–704. doi: 10.1515/bchm3.1995.376.12.697. [DOI] [PubMed] [Google Scholar]
  34. Richardson D. K., Torday J. S. Racial differences in predictive value of the lecithin/sphingomyelin ratio. Am J Obstet Gynecol. 1994 May;170(5 Pt 1):1273–1278. doi: 10.1016/s0002-9378(94)70141-5. [DOI] [PubMed] [Google Scholar]
  35. Tokieda K., Whitsett J. A., Clark J. C., Weaver T. E., Ikeda K., McConnell K. B., Jobe A. H., Ikegami M., Iwamoto H. S. Pulmonary dysfunction in neonatal SP-B-deficient mice. Am J Physiol. 1997 Oct;273(4 Pt 1):L875–L882. doi: 10.1152/ajplung.1997.273.4.L875. [DOI] [PubMed] [Google Scholar]
  36. Veletza S. V., Rogan P. K., TenHave T., Olowe S. A., Floros J. Racial differences in allelic distribution at the human pulmonary surfactant protein B gene locus (SP-B). Exp Lung Res. 1996 Jul-Aug;22(4):489–494. doi: 10.3109/01902149609046037. [DOI] [PubMed] [Google Scholar]
  37. Venkitaraman A. R., Hall S. B., Whitsett J. A., Notter R. H. Enhancement of biophysical activity of lung surfactant extracts and phospholipid-apoprotein mixtures by surfactant protein A. Chem Phys Lipids. 1990 Dec;56(2-3):185–194. doi: 10.1016/0009-3084(90)90101-v. [DOI] [PubMed] [Google Scholar]
  38. Voss T., Melchers K., Scheirle G., Schäfer K. P. Structural comparison of recombinant pulmonary surfactant protein SP-A derived from two human coding sequences: implications for the chain composition of natural human SP-A. Am J Respir Cell Mol Biol. 1991 Jan;4(1):88–94. doi: 10.1165/ajrcmb/4.1.88. [DOI] [PubMed] [Google Scholar]
  39. Yukitake K., Brown C. L., Schlueter M. A., Clements J. A., Hawgood S. Surfactant apoprotein A modifies the inhibitory effect of plasma proteins on surfactant activity in vivo. Pediatr Res. 1995 Jan;37(1):21–25. [PubMed] [Google Scholar]
  40. de la Chapelle A. Disease gene mapping in isolated human populations: the example of Finland. J Med Genet. 1993 Oct;30(10):857–865. doi: 10.1136/jmg.30.10.857. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. deMello D. E., Heyman S., Phelps D. S., Floros J. Immunogold localization of SP-A in lungs of infants dying from respiratory distress syndrome. Am J Pathol. 1993 May;142(5):1631–1640. [PMC free article] [PubMed] [Google Scholar]
  42. deMello D. E., Phelps D. S., Patel G., Floros J., Lagunoff D. Expression of the 35kDa and low molecular weight surfactant-associated proteins in the lungs of infants dying with respiratory distress syndrome. Am J Pathol. 1989 Jun;134(6):1285–1293. [PMC free article] [PubMed] [Google Scholar]

Articles from American Journal of Human Genetics are provided here courtesy of American Society of Human Genetics

RESOURCES